Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Antibiotic therapy and fat digestion and absorption in cystic fibrosis.

Lisowska A, Pogorzelski A, Oracz G, Skorupa W, Cofta S, Szydłowski J, Socha J, Walkowiak J.

Acta Biochim Pol. 2011;58(3):345-7. Epub 2011 Jul 7.

2.

Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth.

Lisowska A, Pogorzelski A, Oracz G, Siuda K, Skorupa W, Rachel M, Cofta S, Piorunek T, Walkowiak J.

J Cyst Fibros. 2011 Dec;10(6):418-21. doi: 10.1016/j.jcf.2011.06.008. Epub 2011 Jul 20.

3.

Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.

Van de Vijver E, Desager K, Mulberg AE, Staelens S, Verkade HJ, Bodewes FA, Malfroot A, Hauser B, Sinaasappel M, Van Biervliet S, Behm M, Pelckmans P, Callens D, Veereman-Wauters G.

J Pediatr Gastroenterol Nutr. 2011 Jul;53(1):61-4. doi: 10.1097/MPG.0b013e31820e208e.

PMID:
21694537
4.

Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.

Trapnell BC, Maguiness K, Graff GR, Boyd D, Beckmann K, Caras S.

J Cyst Fibros. 2009 Dec;8(6):370-7. doi: 10.1016/j.jcf.2009.08.008. Epub 2009 Oct 7.

5.

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.

Church DA, Kanga JF, Kuhn RJ, Rubio TT, Spohn WA, Stevens JC, Painter BG, Thurberg BE, Haverstock DC, Perroncel RY, Echols RM.

Pediatr Infect Dis J. 1997 Jan;16(1):97-105; discussion 123-6.

PMID:
9002118
6.

Evaluation of the 13C-triolein breath test for fat malabsorption in adult patients with cystic fibrosis.

Ritz MA, Fraser RJ, Di Matteo AC, Greville H, Butler R, Cmielewski P, Davidson G.

J Gastroenterol Hepatol. 2004 Apr;19(4):448-53.

PMID:
15012784
7.

Measurement of fat digestion in early life using a stable isotope breath test.

McClean P, Harding M, Coward WA, Green MR, Weaver LT.

Arch Dis Child. 1993 Sep;69(3):366-70.

8.

Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis.

Francisco MP, Wagner MH, Sherman JM, Theriaque D, Bowser E, Novak DA.

J Pediatr Gastroenterol Nutr. 2002 Jul;35(1):79-83.

PMID:
12142815
9.

Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.

Schaad UB, Wedgwood-Krucko J, Guenin K, Buehlmann U, Kraemer R.

Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):858-65.

PMID:
2512129
10.

Lipid digestion in cystic fibrosis: comparison of conventional and high-lipase enzyme therapy using the mixed-triglyceride breath test.

De Boeck K, Delbeke I, Eggermont E, Veereman-Wauters G, Ghoos Y.

J Pediatr Gastroenterol Nutr. 1998 Apr;26(4):408-11.

PMID:
9552136
11.

Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice.

Wouthuyzen-Bakker M, Bodewes FA, Verkade HJ.

J Cyst Fibros. 2011 May;10(3):150-8. doi: 10.1016/j.jcf.2011.03.008. Epub 2011 Apr 2. Review.

13.

Evaluation studies of the 13C-mixed triglyceride breath test in healthy controls and adult cystic fibrosis patients with exocrine pancreatic insufficiency.

Swart GR, Baartman EA, Wattimena JL, Rietveld T, Overbeek SE, van den Berg JW.

Digestion. 1997;58(5):415-20.

PMID:
9383631
14.

Study of a novel pancreatic enzyme replacement therapy in pancreatic insufficient subjects with cystic fibrosis.

Borowitz D, Goss CH, Limauro S, Konstan MW, Blake K, Casey S, Quittner AL, Murray FT.

J Pediatr. 2006 Nov;149(5):658-662.

PMID:
17095338
15.

Effect of elective antibiotic therapy on resting energy expenditure and inflammation in cystic fibrosis.

Burdet L, Hugli O, Aubert JD, Schutz Y, Roulet M, Fitting JW.

Eur J Pediatr. 1999 Sep;158(9):711-6.

PMID:
10485301
16.

13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis.

Amarri S, Harding M, Coward WA, Evans TJ, Weaver LT.

Arch Dis Child. 1997 Apr;76(4):349-51.

17.

Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids.

Kalivianakis M, Minich DM, Bijleveld CM, van Aalderen WM, Stellaard F, Laseur M, Vonk RJ, Verkade HJ.

Am J Clin Nutr. 1999 Jan;69(1):127-34.

18.

Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.

Colombo C, Costantini D, Rocchi A, Cariani L, Garlaschi ML, Tirelli S, Calori G, Copreni E, Conese M.

Pediatr Pulmonol. 2005 Jul;40(1):15-21.

PMID:
15858808
19.

13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis.

Domínguez-Muñoz JE, Iglesias-García J, Vilariño-Insua M, Iglesias-Rey M.

Clin Gastroenterol Hepatol. 2007 Apr;5(4):484-8. Erratum in: Clin Gastroenterol Hepatol. 2011 Dec;9(12):1108.

PMID:
17445754
20.

Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis.

Schaad UB, Wedgwood J, Ruedeberg A, Kraemer R, Hampel B.

Pediatr Infect Dis J. 1997 Jan;16(1):106-11; discussion 123-6.

PMID:
9002119
Items per page

Supplemental Content

Write to the Help Desk